NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/10/2026
Back to search
Official data from USPTO
IMFOCY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
02/11/2026
Trademark type
Combined
Nice classes
5, 9, 10
Filing date
07/03/2025
Registration date
02/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/10/2026
Last transaction
02/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Hamburg, DE
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "IMFOCY" in purple to the right of a design featuring a purple "V" overlapping a green "V". Within the purple "V" is a green circle and within the green "V" is a purple circle and each resembles a person with raised arms.
Holders and representatives
Holders
Alfred E. Tiefenbacher GmbH & Co. KG
Representatives
Seth I Appel Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of neurodevelopmental and neurological diseases
Class 9
Downloadable computer software platforms for use in dosing pharmaceuticals and medication management for the treatment of neurological and neurodevelopmental diseases; downloadable software in the nature of a mobile application for use in dosing pharmaceuticals and medication management for the treatment of neurological and neurodevelopmental diseases
Class 10
Dosage dispensers for administering medicine to patientsmedical dispensers with dosage function for administering pharmaceuticals for the treatment of neurodevelopmental and neurological diseasesin particular for pharmaceuticals in the form of pellets and tablets
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/10/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/23/2025
PUBO
PUBLISHED FOR OPPOSITION
12/23/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/17/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/01/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
11/30/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/30/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
11/30/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/30/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/10/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/10/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/02/2025
GNSL
LETTER OF SUSPENSION E-MAILED
09/02/2025
CNSL
SUSPENSION LETTER WRITTEN
09/02/2025
DOCK
ASSIGNED TO EXAMINER
08/27/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/27/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/27/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/03/2025
NWAP
NEW APPLICATION ENTERED
07/03/2025
Continuous trademark protection
Get notified about every new filing that threatens IMFOCY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.